Lactic acidosis , though rare (approximately 3 cases per 100,000 patient-years), represents metformin's most serious potential adverse effect
Indian companies are also developing a biosimilar for semaglutide where it seems that the patent will not be respected after 2026
Many people dont want to be so dependent on pharmaceuticals, which microdosing supports, says Jordan
It's only approved to treat type 2 diabetes, but people taking it do lose weight
PMID: 37931265
A clinical trial for diabetes that pit orforglipron, a diabetes and weight-loss pill developed by Eli Lilly, against oral semaglutide, made by Novo Nordisk, suggests the former pill may have the edge in reducing blood sugar and weight